Coherus BioSciences Inc. (CHRS) Leaped After Patent Victory

Thursday, 18 May 2017  (1 week ago)
Coherus BioSciences Inc. (CHRS) announced Tuesday that the Patent Trial and Appeal Board ruled in its favor in a case against AbbVie (ABBV) over U.S. Patent 8,889,135.

Related Videos


Wochit News -   ▶  00:39

Advertisement

Bloomberg Technology -   ▶  02:38

Recent related news

Advertisement
BOSTON--(BUSINESS WIRE)--#cancer--MetaStat, Inc. (OTCQB: MTST), a personalized medicine company developing therapeutic and diagnostic treatment solutions for...
2 days ago • Business Wire
The U.S. Supreme Court handed down a ruling on Monday that will sharply limit the places where companies can file patent infringement lawsuits, a move that is...
3 days ago • SFGate
The U.S. Supreme Court ruled Monday to severely limit the ability of patent holders to file infringement lawsuits in courts that have a reputation of siding with...
2 days ago • bizjournals
A novel approach to fighting cancer being developed in Birmingham that is in a preclinical phase has received a European patent. The University of Alabama at...
17 hours ago • bizjournals
The U.S. Patent and Trademark Office (USPTO) is implementing eCommerce Modernization (eMod), as discussed at a Patent Quality Chat webinar on May 9, 2017....
6 days ago • Mondaq
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,656,070....
3 days ago • Business Wire

You might like